SEC Comment Letter 0000000000-25-003235 to Verastem, Inc. (VSTM)
Verastem, Inc.
Date: March 26, 2025 · CIK: 0001526119 · Accession: 0000000000-25-003235
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285972
Letter
Re: Verastem, Inc. Registration Statement on Form S-3 Filed March 20, 2025 File No. 333-285972 Dear Daniel Paterson:
March 26, 2025
Daniel Paterson Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, MA 02494
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Thomas Danielski
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 26, 2025 Daniel Paterson Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, MA 02494 Re: Verastem, Inc. Registration Statement on Form S-3 Filed March 20, 2025 File No. 333-285972 Dear Daniel Paterson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Thomas Danielski </TEXT> </DOCUMENT>